References

Barker CI, Standing J, Kelly L Pharmacokinetic studies in children: recommendations for practice and research. Arch Dis Child.. 2018; 103:(7)695-702

Batchelor HK, Marriott JF Paediatric pharmacokinetics: key considerations. Br J Clin Pharmacol.. 2015; 79:(3)395-404 https://doi.org/10.1111/bcp.12267

Bertram JF, Douglas-Denton RN, Diouf B, Hughson MD, Hoy WE Human nephron number: implications for health and disease. Pediatr Nephrol.. 2011; 26:(9)1529-33

Chuang GT, Tsai IJ, Tsau YK Serum Creatinine Reference Limits in Pediatric Population-A Single Center Electronic Health Record-Based Database in Taiwan. Front Pediatr. 2021; 9 https://doi.org/10.3389/fped.2021.793446

Eidelman C, Abdel-Rahman SM Pharmacokinetic considerations when prescribing for children. International Journal of Pharmacokinetics.. 2016; 1:(1)69-80 https://doi.org/10.4155/ipk-2016-0001

Hill B, Allan J, Camara C In: Peate I, Dryden P West Sussex: Wiley Blackwell; 2022

Kearns GL, Abdel-Rahman SM, Alander SW, Blowey DL, Leeder S, Kauffman RE Developmental pharmacology - drug disposition, action and therapy in infants and children. N Engl J Med.. 2003; 349:(12)1157-67 https://doi.org/10.1056/NEJMra035092

Lu H, Rosenbaum S Developmental Pharmacokinetics in Pediatric Populations. J Pediatr Pharmacol Ther. 2014; 19:(4)262-76 https://doi.org/10.5863/1551-6776-19.4.262

Manalich R, Reyes L, Herrera M, Melendi C, Fundora I Relationship between weight at birth and the number and size of renal glomeruli in humans: a histomorphometric study. Kidney Int.. 2000; 58:(2)770-3 https://doi.org/10.1046/j.1523-1755.2000.00225.x

O'Hara K Paediatric pharmacokinetics and drug doses. Aust Prescr.. 2016; 39:(6)208-210

O'Hara K, Wright IM, Schneider JJ, Jones AL, Martin JH Pharmacokinetics in neonatal prescribing: evidence base, paradigms and the future. Br J Clin Pharmacol.. 2015; 80:(6)1281-8 https://doi.org/10.1111/bcp.12741

Pierrat A, Gravier E, Saunders CM Predicting GFR in children and adults: a comparison of the Cockcroft-Gault, Schwartz, and modification of diet in renal disease formulas. Kidney Int.. 2003; 64:(4)1425-36 https://doi.org/10.1046/j.1523-1755.2003.00208.x

Sage DP, Kulczar C, Roth W, Liu W, Knipp GT Persistent pharmacokinetic challenges to pediatric drug development. Front Genet. 2014; 5

Schwartz GJ, Munoz A, Schneider MF New equations to estimate GFR in children with CKD. J Am Soc Nephrol.. 2009; 20:(3)629-37

Van den Anker J, Reed MD, Allegaert K, Kearns G Developmental Changes in Pharmacokinetics and Pharmacodynamics. J Clin Pharmacol. 2018; 58:(Suppl 10)S10-S25 https://doi.org/10.1002/jcph.1284

A–Z of prescribing for children

02 February 2024
Volume 6 · Issue 2

Abstract

This series focuses on aspects of prescribing for neonates, children and young people, from A—Z. Aspects of pharmacokinetics will be considered, alongside legal considerations, consent and medications in schools

Excretion is the final phase of the drug's journey as it passes through the body, and this elimination – usually by the kidneys – depends on glomerular filtration, tubular excretion and also tubular reabsorption (Van den Anker et al, 2018). However, the processes are clearly influenced by nephrogenesis – or the kidney's development – in an infant (Sage et al, 2014).

Normal nephrogenesis begins at 9 weeks' gestation and is complete by 36 weeks' gestation, which is then followed by postnatal changes in the blood flow in the kidney (Kearns et al, 2003). Therefore, premature and low birthweight babies will have under-developed kidneys: lower birthweight babies will have fewer glomeruli per unit area in the cortex than normal birthweight babies (Manalich et al, 2000). Nevertheless, term babies' kidneys will be nephrogenetically complete, as there are no more nephrons formed after 36 weeks' gestation (Bertram et al, 2011). However, the kidney still does not reach full maturity until the child reaches puberty (Eidelman and Abdel-Rahman, 2016), and structural differences are well described between neonate and adult kidneys (Box 1).

Register now to continue reading

Thank you for visiting Journal of Prescribing Practice and reading some of our peer-reviewed resources for prescribing professionals. To read more, please register today. You’ll enjoy the following great benefits:

What's included

  • Limited access to our clinical or professional articles

  • New content and clinical newsletter updates each month